Skip to main content

Table 4 Prevalence of sarcopenia and sarcopenia categories according to CKD-EPI eGFR (ml/min/1.73m2) categories

From: Prevalence of sarcopenia in community-dwelling older adults using the updated EWGSOP2 definition according to kidney function and albuminuria

  Non-sarcopenic (n = 1270) Sarcopenic (n = 150) p-value
CKD-EPI eGFR category No sarcopenia (n = 1114) Probable sarcopenia (n = 156) Confirmed sarcopenia (n = 65) Severe sarcopenia (n = 85)
≥90 (n = 42) 37 (88.1%) 5 (11.9%) 0.774
29 (69.0%) 8 (19.0%) 3 (7.1%) 2 (4.8%)  
60–89 (n = 884) 795 (89.9%) 89 (10.1%) 0.435
720 (81.4%) 75 (8.5%) 46 (5.2%) 43 (4.9%)  
45–59 (n = 247) 226 (91.5%) 21 (8.5%) 0.246
194 (78.5%) 32 (13.0%) 5 (2.0%) 16 (6.5%)  
30–44 (n = 163) 139 (85.3%) 24 (14.7%) 0.066
112 (68.7%) 27 (16.6%) 9 (5.5%) 15 (9.2%)  
15–29 (n = 84) 73 (86.9%) 11 (13.1%) 0.436
59 (70.2%) 14 (16.7%) 2 (2.4%) 9 (10.7%)  
≥60 (n = 1173) 1058 (90.2%) 115 (9.8%) 0.042
943 (80.4%) 115 (9.8%) 54 (4.6%) 61 (5.2%)
< 60 (n = 247) 212 (85.8%) 35 (14.2%)
171 (69.2%) 41 (16.6%) 11 (4.5%) 24 (9.7%)
  1. CKD-EPI Chronic Kidney Disease Epidemiological Collaboration, eGFR Estimated glomerular filtration rate